- Ashland Board appoints Ashish K. Kulkarni as new director
- Ashland board authorizes quarterly dividend
- Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital Partners
- Ashland reports financial results1 for second quarter fiscal 2024; issues outlook for third quarter and full-year fiscal 2024
- Ashland sets date for fiscal 2024 second-quarter earnings release and conference call webcast
- Ashland Board appoints Scott A. Tozier as new director
- Ashland announces executive organization changes to personal care and specialty additives
- Ashland drives gender parity, shines spotlight on the inspirational power of women from lab bench to real life, and announces Responsible Solvers™ speaker series
- Ashland reports financial results1 for first quarter fiscal 2024; issues outlook for second quarter and full-year fiscal 2024
- Ashland sets date for fiscal 2024 first-quarter earnings release and conference call webcast
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 1,812.07 |
Average volume | -- |
---|---|
Shares outstanding | 50.13m |
Free float | 49.84m |
P/E (TTM) | 27.82 |
Market cap | 4.91bn USD |
EPS (TTM) | 3.52 USD |
Annual div (ADY) | 27.09 MXN |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | Feb 29 2024 |
Div pay-date | Mar 15 2024 |
Next div ex-date | May 31 2024 |
Next div pay-date | Jun 15 2024 |
Data delayed at least 20 minutes, as of Mar 09 2023.
More ▼